| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/25/2009 | US20090163729 Compositions and methods for using acyltransferases for altering lipid production on the surface of plants |
| 06/25/2009 | US20090163702 siRNA targeting Myeloid cell leukemia sequence 1 |
| 06/25/2009 | US20090163701 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 06/25/2009 | US20090163460 Diagnostics and therapeutics for early-onset menopause |
| 06/25/2009 | US20090163438 Gankyrin |
| 06/25/2009 | US20090163436 Methods for delivery of nucleic acids |
| 06/25/2009 | US20090163435 miR-200 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 06/25/2009 | US20090163434 miR-20 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 06/25/2009 | US20090163433 Anthelmintic and/or insecticide development |
| 06/25/2009 | US20090163431 Compositions and methods for modulation of pdx-1 |
| 06/25/2009 | US20090163430 Functions and targets of let-7 micro rnas |
| 06/25/2009 | US20090163429 Rna aptamers and methods for identifying the same |
| 06/25/2009 | US20090163407 Compositions and methods for altering wnt autocrine signaling |
| 06/25/2009 | US20090163406 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells |
| 06/25/2009 | US20090163400 Subtilase Variants |
| 06/25/2009 | US20090163397 Novel CBH1 Homologs And Variant CBH1 Cellulases |
| 06/25/2009 | US20090163381 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 06/25/2009 | US20090163376 Ketol-acid reductoisomerase using nadh |
| 06/25/2009 | US20090163370 Competitive N-Hybrid System |
| 06/25/2009 | US20090163368 Directed evolution using proteins comprising unnatural amino acids |
| 06/25/2009 | US20090162937 Compositions and methods comprising the use of cell surface displayed homing endonucleases |
| 06/25/2009 | US20090162936 Method For Transfer Of Gene Into Fat Cell Or Progenitor Fat Cell |
| 06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 06/25/2009 | US20090162932 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
| 06/25/2009 | US20090162931 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 06/25/2009 | US20090162924 Compositions and methods for obtaining nucleic acids from sputum |
| 06/25/2009 | US20090162918 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs; adjuvant |
| 06/25/2009 | US20090162917 Subtilism Carlsberg Proteins With Reduced Immunogencity |
| 06/25/2009 | US20090162915 Peptidylarginine Deiminase 6 |
| 06/25/2009 | US20090162911 Strain for butanol production |
| 06/25/2009 | US20090162910 Method for mass production of primary metabolites, strain for mass production of primary metabolites, and method for preparation thereof |
| 06/25/2009 | US20090162909 Ketoreductase Polypeptides for the Production of Azetidinone |
| 06/25/2009 | US20090162907 Method for producing l-glutamic acid by fermentation accompanied by precipitation |
| 06/25/2009 | US20090162906 Biocatalysts; mutant and/or chemically modified enzymes; stereoselectively hydrolyze an amino nitrile or cyanohydrin intermediate to produce the corresponding carboxylic acid; e.g. phenylglycinonitrile from benzaldehyde, potassium cyanide and ammonium chloride |
| 06/25/2009 | US20090162904 Transgenic plants and methods for controlling bolting in sugar beet |
| 06/25/2009 | US20090162902 Monoclonal antibody that binds protein A from Staphylococcus aureus; use in diagnosis, therapy and detection |
| 06/25/2009 | US20090162900 Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such of such products |
| 06/25/2009 | US20090162898 High copy number self-replicating plasmids in pseudomonas |
| 06/25/2009 | US20090162897 Promoter Sequences |
| 06/25/2009 | US20090162896 Production of Recombinant Collagen Like Proteins |
| 06/25/2009 | US20090162894 A gene encoding a protein having an improved nitrile hydratase activity, whereby heat resistance has been improved or substrate specificity has been changed; for efficient production of acrylamide |
| 06/25/2009 | US20090162893 Alcohol dehydrogenase for the stereoselective production of hydroxy compounds |
| 06/25/2009 | US20090162892 Fermentative production of fine chemicals |
| 06/25/2009 | US20090162889 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein |
| 06/25/2009 | US20090162884 Method of disulfide crosslink forming in vitro protein synthesis |
| 06/25/2009 | US20090162873 Gene encoding a multidrug-resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 06/25/2009 | US20090162871 Using solid support comprising immobilized factor VII activating protease (FSAP) to detect autoantibodies against protease; fibrinolysis a nd blood clotting factors |
| 06/25/2009 | US20090162869 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell |
| 06/25/2009 | US20090162867 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 06/25/2009 | US20090162866 Compositions and methods for obtaining nucleic acids from sputum |
| 06/25/2009 | US20090162865 northern blotting, electrophoresis, PCR |
| 06/25/2009 | US20090162857 Pharmaceutical Compositions and Methods for Delivering Nucleic Acids Into Cells |
| 06/25/2009 | US20090162851 Target-specific hybrid capture (TSHC) for enhanced detection of homologous nucleotide sequences; classifying microorganisms; diagnosing infection, genetic abnormality and cell proliferative disorders; rapid, sensitive, highly specific and capable of discriminating highly homologous nucleic acids |
| 06/25/2009 | US20090162850 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 06/25/2009 | US20090162848 Noxin, a novel stress-induced gene involved in cell cycle and apoptosis |
| 06/25/2009 | US20090162847 Rapid detection of the "high-virulent" st-17 clone of group b streptococcus |
| 06/25/2009 | US20090162844 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase |
| 06/25/2009 | US20090162835 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| 06/25/2009 | US20090162834 Molecular sequence of swine retrovirus and methods of use |
| 06/25/2009 | US20090162832 Functional viral vectors for the overexpression or extinction of particular genes in plants, and applications |
| 06/25/2009 | US20090162831 human parvovirus |
| 06/25/2009 | US20090162526 Generation of plants with altered oil content |
| 06/25/2009 | US20090162422 Single-domain brain-targeting antibody fragments derived from LLAMA antibodies |
| 06/25/2009 | US20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
| 06/25/2009 | US20090162396 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/25/2009 | US20090162391 Vaccine antigens from piscirickettsia salmonis |
| 06/25/2009 | US20090162390 Molecular Scaffolds for HIV-1 Immunogens |
| 06/25/2009 | US20090162388 epitope of salmonid alphaviruses capable of inducing a virus neutralizing immune response |
| 06/25/2009 | US20090162380 Multispecific binding molecules comprising connecting peptides |
| 06/25/2009 | US20090162371 Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 06/25/2009 | US20090162368 Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162365 Novel siRNAS and methods of use thereof |
| 06/25/2009 | US20090162364 Apo-2 ligand |
| 06/25/2009 | US20090162363 Pedf-r receptor and uses |
| 06/25/2009 | US20090162356 CRIg antagonists |
| 06/25/2009 | US20090162349 Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels |
| 06/25/2009 | US20090162347 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/25/2009 | US20090162343 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 06/25/2009 | US20090162341 For inhibition or reduction of exocytic fusion in a nociceptive sensory afferent cell comprising a Targeting Moiety, a non-cytotoxic protease and a Translocation Domain; pain |
| 06/25/2009 | US20090162338 Inhibiting metastasis of cancer cells by administering a phosphatidyl inositol 3-kinase inhibitor such as Wortmannin or LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) |
| 06/25/2009 | US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease |
| 06/25/2009 | US20090162332 Methods and compositions for treating brain diseases |
| 06/25/2009 | US20090162329 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| 06/25/2009 | US20090162320 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 06/25/2009 | US20090162317 Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same |
| 06/25/2009 | US20090162285 Anti-inflammatory fusion protein |
| 06/25/2009 | US20090162284 Anti-igf-i receptor antibody |
| 06/25/2009 | US20090162279 Oligonucleotide or Its Functional Homologue, a Composition Comprising the Same and a Method of Treating B Cell Neoplasm |
| 06/25/2009 | DE202005021713U1 Rekombinante Spinnenseidenproteine Recombinant spider silk proteins |
| 06/25/2009 | DE10345386B4 Rekombinante Hefezellen und Verfahren zum Nachweis von Substanzen mit östrogener Wirkung Recombinant yeast cells, and methods for the detection of substances with estrogenic activity |
| 06/25/2009 | DE102007062962A1 Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg) New surface protein mutant of hepatitis B virus HBV surface antigen (HBsAg) |
| 06/25/2009 | DE102007061929A1 Modified polypeptide capable of lysing bacterial cell walls, useful as a medicament or diagnostic agent, has amino acid substitutions at protease cleavage sites that inhibit degradation by proteases |
| 06/25/2009 | CA2709640A1 Lipid metabolism proteins, combinations of lipid metabolism proteins and uses thereof |
| 06/25/2009 | CA2709404A1 Down-regulation of gene expression using artificial micrornas |
| 06/25/2009 | CA2709333A1 Down-regulation of gene expression using artificial micrornas |
| 06/25/2009 | CA2709054A1 Recombinant cells producing .omega.-aminocarboxylic acids,.omega.-aminocarboxylic acid esters or their lactams |
| 06/25/2009 | CA2708854A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | CA2708836A1 Methods for purifying or depleting molecules or cells of interest |
| 06/25/2009 | CA2708097A1 Lipid metabolism protein and uses thereof iii (pyruvate-orthophosphate-dikinase) |